Hospital Universitario HM Sanchinarro
Hospital Universitario HM Sanchinarro
Spain, Madrid
Antonio Cubillo Gracián
36 years of experience
Clinic is certified :
Biomarker testing for lung cancer in Spain typically costs from $1,000 to $1,500. The final price depends on the testing method used. Some labs use individual tests while others use next-generation sequencing panels. Patients save about 50% compared to the US. Average costs in the US reach $2,400 for similar molecular diagnostics.
Bookimed Expert Insight: Choosing a university-affiliated hospital in Madrid offers access to academic research standards. These facilities often combine clinical care with postgraduate research in oncology. Hospital Universitario HM Sanchinarro treats approximately 400,000 patients every year. Dr. Antonio Cubillo Gracián there leads research specifically in clinical and applied oncology. This high volume and academic focus help in interpreting complex biomarker results correctly.
| Turkey | Austria | Spain | |
| EGFR, ALK, ROS1, PG-L1 | from $450 | from $1,450 | from $950 |
No hidden fees – just official clinic prices. Pay at the clinic for EGFR, ALK, ROS1, PG-L1 upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in EGFR, ALK, ROS1, PG-L1 and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your EGFR, ALK, ROS1, PG-L1 journey.
The doctor is an accomplished educator and researcher in the field of oncology, with extensive teaching experience at USP CEU. The doctor has taught a wide array of subjects including General Medical Pathology, Oral and Maxillofacial Oncology, and Bioethics. As a tutor for medical students and external rotants, the doctor has contributed significantly to the training of future healthcare professionals.
Additionally, the doctor holds the position of Director of postgraduate research in clinical and applied oncology at HM CIOCC USP CEU and is responsible for postgraduate master practices. The doctor has also completed advanced courses at MD Anderson Cancer Center.